Netanel Derovan is Chief Legal Officer of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 149,500 shares of ORMP, which is worth approximately $354,315. The most recent transaction as insider was on May 26, 2023, when has been sold 20,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 150K
0% 3M change
0% 12M change
Total Value Held $354,315

Netanel Derovan Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 26 2023
BUY
Grant, award, or other acquisition
-
20,500 Added 12.06%
149,500 Common Stock
Apr 17 2023
BUY
Grant, award, or other acquisition
-
81,000 Added 38.57%
129,000 Common Stock
Jul 28 2022
BUY
Grant, award, or other acquisition
-
30,000 Added 38.46%
48,000 Common Stock
Jan 09 2022
BUY
Grant, award, or other acquisition
-
18,000 Added 50.0%
18,000 Common Stock
ND

Netanel Derovan

Chief Legal Officer
New York, NY

Track Institutional and Insider Activities on ORMP

Follow ORAMED PHARMACEUTICALS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Track Activities on ORMP